Brief: ImmunoGen Reports Fourth Quarter EPS of USD -0.23
01/03/2023 11:31
Mar 1 (Reuters) - ImmunoGen Q4 EPS USD -0.23 * Q4 revenue USD 41.2 million * Q4 net income USD -59 million
Recent news on ImmunoGen
See all newsBrief: Abbvie Completes Acquisition Of Immunogen
Brief: Abbvie Qtrly Adj EPS $2.79 Vs LSEG IBES Estimate $2.77
Brief: Immunogen Says German Federal Cartel Office Approved Merger With Abbvie Unconditionally
Ambrx Biopharma surges on J&J's buyout announcement
Street View: BioMarin-Elliott settlement likely eases investor frustration